We are live on ! Find out more
CMD

Cantel Medical Corporation
CMD

Delisted

CMD was delisted on the 1st of June, 2021.

0 hedge funds and large institutions have $0 invested in Cantel Medical Corporation in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 234 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2340 (-234)

100% less funds holding in top 10

Funds holding in top 10: 40 (-4)

100% less capital invested

Capital invested by funds: $3.05B → $0 (-$3.05B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 234

Holders
Holders Change
-234
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
234
Calls
Puts
Net Calls
Net Calls Change

CMD Hedge Fund Activity: Q2 2021 in Review

0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q2 2021, worth a combined $0 — down 100% from $3.05B a quarter earlier.

Sellers outnumbered buyers: 234 funds closed out of CMD and 0 opened new positions — a net loss of 234 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $388M sold.

  • 0 institutional investors held Cantel Medical Corporation (CMD) as of Q2 2021, down from 234 in Q1 2021.
  • Funds reported $0 of Cantel Medical Corporation stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Cantel Medical Corporation positions in Q2 2021 and 234 closed out, a net change of -234 holders.
  • The largest Cantel Medical Corporation seller in Q2 2021 was BlackRock, an estimated $388M sold.

Based on aggregated 13F filings for Q2 2021.